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Abstract 
The proportion of older people is increasing in Australia, and the care of older people in 
hospital is a core issue. Hospitalisation is associated with multiple adverse outcomes, and risk 
stratification of this population remains a challenge with lack of a single measure or test. 
There is some evidence to support the measurement of frailty status or physical performance-
based assessment to predict adverse outcomes. Among the instruments to measure frailty, the 
frailty index (FI) based on the principle of deficit accumulation has shown an association 
with adverse events for a hospitalised population. Gait speed (GS), a physical performance 
measure, is also associated with a range of poor outcomes in the community-dwelling 
population.  
The thesis opens with a narrative review of frailty and physical performance measures in 
chapter one. The review explores the pathophysiology of frailty, different methods of 
measuring frailty, and the association between frailty and poor outcomes.  Similar domains 
are then explored for performance-based measures. Of the different approaches to frailty, the 
frailty index model postulates frailty as a continuous risk state. It may be possible to create an 
FI in the hospital setting by collecting a number of variables using a well-defined 
methodology described in the literature. Gait speed is routinely measured in most 
rehabilitation settings and is a simple test to administer. However, the utility of gait speed in 
the hospitalised population remains unknown as it may not be feasible to assess gait speed 
due to the impact of acute illness. This thesis aimed to assess the feasibility and predictive 
validity of frailty index and gait speed in a hospital geriatric rehabilitation setting, to assess 
the correlation between the two measures, and to assess if the combination of FI and GS is a 
better predictor of outcomes. 
Chapter 2 describes the methodology in detail. Participants ≥65 years of age admitted to 
geriatric rehabilitation wards of a tertiary teaching hospital were included in a prospective 
cohort study. A frailty index was derived using routinely collected data using a well -defined 
methodology. Components of the Functional Independence Measure (FIM) medication count 
and comorbidities were used as variables with different cut points to derive the FI. The ward 
physiotherapists measured gait speed at rehabilitation admission using the timed ten- metre 
walk test. Outcome measures included falls, delirium, longer length of stay (>75th percentile) 
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and poor discharge outcome (defined as inpatient mortality or discharge to a higher level of 
care). Data collection was undertaken by audit of medical records.  Descriptive statistics were 
used to determine participant characteristics. Correlation statistics assessed the relationship 
between the FI and GS. Univariate analyses of predictors (FI and GS) against outcomes used 
parametric or nonparametric tests depending on the distribution of the data.   
 
Chapter 3 presents the results of the study. A total of 258 participants were recruited with a 
mean (SD) age of 79(8) years and 54% were females. An FI could be derived for all 
participants; it was normally distributed, conformed to expected characteristics reaching a 
submaximal limit of 0.69. Only half the participants were able to undertake the gait speed 
assessment on admission to rehabilitation. Those unable to undertake the assessment were 
allocated a gait speed of zero. There was a weak but significant inverse relationship between 
FI and gait speed (correlation coefficient -0.396). Both parameters were significantly 
associated with longer length of stay (p<0.001), poor discharge outcome (p≤0.001) and 
delirium (p<0.05).The prevalence of adverse outcomes was highest in the cohort who were 
frailer and unable to mobilise at admission to rehabilitation. 
 
Chapter 4 discusses the clinical implications of results, contextualizes the findings with other 
studies, evaluates overall strengths and limitations and considers future directions. Among 
older inpatients in a rehabilitation setting, the correlation between FI and GS is weak 
suggesting they measure different aspects of vulnerability. Each predicts adverse outcomes, 
but the combination of high FI and gait speed of zero is associated with the poorest outcomes. 
Future work should investigate whether targeted interventions or more extended periods of 
rehabilitation could be beneficial for this group. 
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Introduction
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OVERVIEW 
 
The population of older people in Australia is increasing, and care of the elderly is an 
essential issue in acute hospitals. People aged 65 years or older comprise an increasing 
proportion of hospital admissions [1, 2]. Frailty is a core concept in the care of older people 
but to define frailty precisely and to know the exact components to measure frailty is an 
ongoing challenge. In this chapter, the concept of frailty is explored and the different ways to 
measure frailty are appraised and summarised in a table. Physical performance measures are 
reviewed, with particular focus on gait speed and its relationship to frailty status. These 
narrative reviews provide the context for study hypotheses, aims and objectives.  
 
 
1.1 Background and Review 
Frailty status and associations 
 
Why is frailty important?  
As an individual acquires comorbidities with ageing, deficits accumulate across multiple 
systems along with normal physiologic changes in ageing and reach a threshold where minor 
insults lead to adverse outcomes. The prevalence of frailty increases with age, and the chance 
of recovery to fitter state after significant health changes also decreases with age [3]. With an 
ageing population, distinguishing frail older people from non-frail is essential in clinical 
practice to choose appropriate interventions, to avoid therapeutic nihilism based on age alone 
and to make informed decisions with patients and family [4]. 
 
Frailty and chronic disease 
Frailty is not synonymous with comorbidities but an effect seen as a result of accumulating 
comorbidities causing likely biological changes resulting in a frail state with disabilities 
accompanying that state [5]. There is individual variation in how people tolerate multiple 
comorbidities. Conceptually, multiple comorbidities can result in biologic changes which in 
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combination with physiological changes may contribute to the pathogenesis of frailty. 
However, interventions aimed at controlling these comorbidities in a frail patient may not 
have an effect on modulating the progression of frailty [6]. 
In a study comparing the predictive ability of diabetes, frailty and comorbidities in relation to 
mortality, frailty was a strong predictor of mortality in elderly population [7]. Elderly people 
with chronic renal disease are shown to have more prevalent frail state [8]. Frailty is 
associated with increased risk of death in elderly patients with end-stage renal failure on 
dialysis [9]. 
Extremes of body mass index are shown to be linked with frailty along with high waist 
circumference [10]. Phenotypic definition of frailty correlated well with extremes of BMI 
with lowest frailty status seen in BMI between 25 and 29.9 [10].A population-based 
prospective study showed that frailty was associated with the development of non-
Alzheimer’s type dementia [11]. Cardiovascular disease status measured by carotid 
ultrasound, ankle-arm index and left ventricular hypertrophy showed a positive relationship 
to frailty [12]. Frailty status impacts clinical management scenarios, for example, 
antithrombotic therapy usage in frail patients appear much less compared with non-frail 
patients as found in one study using Edmonton frailty scale [13].  
Although frailty is related to co-morbidity, they are not synonymous. Therefore 
measuring illness burden is unlikely to give a precise measure of overall health status.  
 
Frailty and quality of life 
Self-reported health rating correlates well with frailty and deficit accumulation. 
Questionnaire-based assessment of self-rated health status was studied in a Canadian study 
involving 1718 patients. The self-rated health deficit index had a moderate correlation with 
the frailty index, and both frailty and the self-rated index predicted mortality [14]. Men and 
women with a high level of psychological well-being in later life have shown to have lower 
frailty levels [15]. In residential care setting, self-reported quality of life was poor in frail 
population [16]. The self-reported questionnaire based frailty definition (SF-36) was studied 
by Johansen et al. and was shown to have 90% sensitivity in predicting frail status when 
compared with phenotype model in patients receiving haemodialysis, but specificity was 64% 
[17]. Quality of life measurement alone will not give an accurate reflection of a 
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vulnerable state but potentially can be used for screening for further detailed 
assessment. 
 
Frailty pathophysiology 
The exact pathophysiology of frailty has not yet been established. Higher blood pressure, 
abdominal fat and cardiovascular risk factors like low high-density lipoprotein (HDL) are 
linked with the frailty syndrome [18]. Frail people are shown to have a greater comorbid 
burden, angiographic disease, poor health status than non-frail people undergoing 
percutaneous coronary intervention [19]. Oxidative stress and inflammation are all 
considered in the pathophysiology of frailty and remain an ongoing area of research [20]. 
Acute medical compromise and injuries set back the complex multisystem threshold in frail 
patients leading to disability [21]. Bioelectrical impedance spectroscopy (BIS)-derived 
estimates of intracellular water (ICW), fat mass, and extracellular water (ECW) were studied 
in renal patients which showed higher ECW volume and high-fat mass to be linked with 
frailty [22]. Central obesity and abdominal fat distribution correlate well with frail status in 
HIV infected older adults [23]. A prospective cohort study showed a correlation of low free 
testosterone and frailty in elderly males [24]. Alterations in the white cell count, neutrophils, 
monocyte counts, T cell subsets, IGF levels are all studied in the pathophysiology of frailty 
[25, 26].  
Given the diversity of possible mechanisms underlying the pathophysiology of frailty, 
identifying a simple biomarker to correlate with the incidence or prevalence of frailty 
will remain a challenge.  
 
 
 
 
22 
 
1.2 Measurement of Frailty 
The measurement of frailty can be broadly classified into three main approaches- phenotypic 
model, risk state and subjective scales. 
 
Phenotypic Model 
Unintentional weight loss, self-reported exhaustion, weakness in grip strength, slow walking 
speed and low physical activity were used in defining frailty status in the Fried phenotype 
model [5]. The presence of three or more of the above characteristics defined someone as 
frail. The frailty phenotype derived from this model showed a significant association with 
falls, disability, death, and institutionalisation [5]. 
The FRAIL scale used five domains -fatigue, resistance (ability to climb a single flight of 
stairs), ambulation (ability to walk 100m), illnesses (>5), and loss of weight of more than 5%, 
tested in the Australian setting. Each of the domains was given a score of 1 if present and the 
scale ranged from 0 to a maximum of 5. Scores of more than two were considered as frail. 
This showed higher levels of frailty correlating with mortality and disability. Even though 
this is named as FRAIL scale, it classifies patient groups as the frail and non-frail group 
similar to phenotypic model [27]. 
 
Frailty Index 
The Frailty index, developed as the proportion of specific deficits present across different 
systems was operationalised by Rockwood et al. [28]. 40 items counted across multiple 
domains measurable by comprehensive geriatric assessment were given a score of 1 if the 
deficit was present, 0 if the deficit was absent, 0.5 if it was present to a limited extent. The 
resulting index score is used as frailty index [28]. Frailty index measured based on deficit 
accumulation serves as an individual variable correlating with disease severity and mortality 
[29]. Higher Frailty index scores are associated with health care utilisation, mortality and 
increasing prevalence with advancing age. Chance of recovery to complete near normal 
premorbid state after acute decompensation reduces with advancing age and worsening frailty 
index scores [3]. 
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A Frailty index (FI) can be derived from routine comprehensive geriatric assessment (CGA) 
with measurements from impairments, comorbidities, disability –FI CGA. This has shown to 
be related to adverse outcomes in the severely frail group. FI CGA is further categorised as 
mild- FICGA<7, moderate- FICGA 7-13 and severe >13[30].Frailty status measured using FI 
at hospital admission predicts adverse outcomes[31]. It is also possible to derive an FI based 
on electronic data in primary care settings [32, 33].  
 
Frailty Scales 
The Canadian Study of Health and Ageing developed The CSHA Clinical Frailty Scale  
(CFS) classifying states from very fit to severely frail state ranging from 1 to 7 [34]. The CFS 
correlated well with the frailty index [34]. Another model is Geriatrician’s Clinical 
Impression of Frailty (GCIF) derived from routine comprehensive geriatric assessment 
measured across multiple domains. Frail status rated from 1 to 5 describing minimal to 
maximum frailty based on the clinical judgement by the clinician. This model does involve 
the clinician’s subjective assessment of the frail status [35]. 
The Edmonton frailty scale (EFS) uses ten domains with a maximum score of 17 which 
indicates a severe frail state. Mood, functional independence, medication use, social support, 
nutrition, health attitudes, continence, the burden of medical illness, quality of life along with 
timed up and go test, clock face drawing for cognitive assessment were used as 
components[36]. The EFS used in preoperative clinic predicted postoperative complications 
in patients with high EFS scores [37]. The Reported Edmonton Frailty score used a modified 
version of Edmonton frailty scale with domains across cognition, general health status, 
functional independence, social support, medication use, nutrition, mood, continence, self-
reported performance. This scale studied in the Australian setting showed a good correlation 
with a geriatrician’s clinical impression of frailty [35]. Modified frailty score using five 
alternative frailty measures—weight loss, low grip strength, slow timed get-up-and-go, 
MMSE ≤24 and FEV1 ≤30% predicted, was more discriminatory than Fried phenotype group 
in moderate to severe frail group [38].  
Each of these approaches has its advantages and disadvantages. Compared to the Fried 
phenotypic definition of frailty which describes frailty as a dichotomous state [frail and non-
frail groups], the frailty index model characterises frailty to be a continuous state of deficit 
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accumulation across multiple systems deriving a numerical index. The frailty scales in use 
also classify varying levels of frailty. Different components, advantages and disadvantages of 
each method are described in the table below. 
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Table 1.1 Frailty Measurement Methods 
Method  Components Frailty definition Advantages Disadvantages 
Fried Phenotype Unintentional weight loss, 
self-reported exhaustion, 
weakness in grip strength, 
slow walking speed and low 
physical activity 
 
  
3 or more- Frail  -Easy to administer 
-Well validated 
 
-Dichotomous classification 
-Lack of inclusion of 
psychosocial domains 
-Dependence on physical 
measures like gait speed 
,grip strength which can be 
challenging in hospital 
setting 
 
Frailty index(FI) 40 items counted across 
multiple domains 
measurable by 
comprehensive geriatric 
assessment were given a 
score of 1 if the deficit was 
present, 0 if deficit was 
absent, 0.5 if it was present 
0.25 –cut off for frail state Multidimensional 
assessment 
-Postulates frailty as a 
continuous state of deficit 
accumulation 
-Evidence to predict 
adverse outcomes 
-Amount of detail and time 
needed in derivation 
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to a limited extent. The 
resulting index score is used 
as frailty index 
 
FI-CGA Frailty index (FI)  derived 
from routine comprehensive 
geriatric assessment (CGA) 
with measurements from 
impairments, comorbidities, 
disability –FI CGA 
0.25 –cut off for frail state -Multidimensional 
assessment 
-Evidence to predict 
adverse outcomes 
-Takes less time than 
conventional FI 
-Able to be used in routine 
care as derived from 
components of CGA 
-Difficult to apply in 
settings where CGA is not 
possible 
-Less time consuming than 
traditional FI but still 
involves time needed for a 
comprehensive geriatric 
assessment  
FRAIL scale Uses five domains -fatigue, 
resistance (ability to climb a 
single flight of stairs), 
ambulation (ability to walk 
100m), illnesses (>5), and 
loss of weight of more than 
5%, 
Each of the domains are 
given a score of 1 if present 
and the scale ranged from 0 
to maximum of 5. Scores of 
more than 2 were 
considered as frail. 
-Ease of measurement 
-No special tests like timed 
walk 
-No need of trained staff 
-No special equipment need 
like dynamometer 
-Similar to Fried phenotype 
model in dichotomising 
frailty 
-More studies needed for 
validation 
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Clinical Frailty Scale   Classifies frailty from very 
fit to severely frail state 
ranging from 1 to 7 
-Visual chart with written 
description of that state 
used 
Score of ≥5 considered as 
frail 
-Ease of use in clinical 
practice 
-Less need of trained staff  
-Able to be derived from 
CGA 
 
-Classification based on 
individual judgement of 
clinician 
Geriatrician’s Clinical 
Impression of Frailty 
(GCIF) 
Derived from routine 
comprehensive geriatric 
assessment measured across 
seven domains- 
 Contributors to 
frailty(Health attitudes, 
mood, balance/mobility, 
burden of medical 
illness, continence, 
nutrition, cognition, social 
support 
and medication issues), 
Frail status rated from 1 to 
5 for most domains 
describing minimal to 
maximum frailty based on 
the clinical judgement by 
the clinician. 
Maximum score is 35. 
-Ability to be derived from 
routine geriatric assessment 
-Multidimensional 
 
-Subjectiveness of 
classification by assessing 
Geriatrician. 
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Atypical presentations 
of acute illness, 
Physical frailty, 
Physiological frailty, 
Frailty as disability, 
Dynamic frailty 
Edmonton frailty scale 
(EFS) 
Mood, functional 
independence, medication 
use, social support, 
nutrition, health attitudes, 
continence, burden of 
medical illness, quality of 
life along with timed up and 
go test, clock face drawing 
for cognitive assessment 
used as components 
Ten domains with a 
maximum score of 17 
which indicates a severe 
frail state. 
0 to 5- Not frail 
6 to 7-apparently vulnerable 
Mild frailty-8 to 9 
Moderate frailty-10 to 11 
Severe frailty-12-17 
 
-Covers multiple domains 
-More simple than FI 
 
-Not as comprehensive as 
other measures 
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Reported Edmonton 
Frailty score 
Modified version of 
Edmonton frailty scale with 
domains across cognition, 
general health status, 
functional independence, 
social support, medication 
use, nutrition, mood, 
continence, self-reported 
performance 
Maximum score-18 
0 to 5- Not frail 
6 to 7-apparently vulnerable 
Mild frailty-8 to 9 
Moderate frailty-10 to 11 
Severe frailty-12-18 
 
-Has shown good 
correlation with 
Geriatrician assessment of 
frailty in acute inpatients 
-Can be administered by 
non trained staff 
-Not comprehensive as 
other measures 
Modified frailty score Using  five alternative 
frailty measures—weight 
loss, low grip strength, slow 
timed get-up-and-go, 
MMSE ≤24 and FEV1 
≤30% predicted 
Score 0- not frail 
1-2- Pre frail 
3 to 5- Frail 
-Simple items 
-Correlates with FI, Fried 
criteria 
 
-Needs further validation 
-Some components may be 
difficult to measure in 
severely frail group 
-Involves usage of special 
equipment like 
dynamometer, spirometry 
assessment tools. 
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1.3 Performance-based assessments 
Performance-based tests (such as gait speed, timed up and go test,chair rise time and balance 
assessments) have been studied in relation to adverse outcomes in the elderly population. The 
assessment of physical performance measures in the severely frail group will have its 
challenge in the form of difficulty in completing the task [38]. 
Pathophysiology 
Integration of multiple body systems is needed for bipedal ambulation [39]. Central nervous 
system, perceptual systems, peripheral nervous system, muscles, bone/joints, and energy 
production/delivery are essential determinants [39]. Deficits across these systems with 
physiological ageing and comorbidities can contribute to slowness. Understanding 
pathophysiology helps in formulating targets for prevention and improvement of these 
parameters. 
Studies analysing the relationship between inflammatory markers and physical performance 
measures have shown that there is a possible inverse relationship between interleukin 6 level 
and 6-minute walking speed [40]. The microstructural integrity of cerebrovascular white 
matter disease seems to influence slowness in walking speed [41]. Higher BMI and 
abdominal / thigh adiposity have been linked with poorer functional performance [42]. Also, 
high-density lipoprotein (HDL) level measured in 364 older adults more than 80 years of age 
showed that functional performance was better with high HDL cholesterol levels [43]. 
Thirteen-week supplementation of vitamin D and whey protein supplements showed 
improvement in lower extremity physical function and muscle mass in elderly population 
[44]. Also, combined exercise training and nutritional supplementation improved handgrip 
strength and quality of life scores in pre-frail elderly women [45]. Mid-arm muscle 
circumference, calf circumference, 4-meter walk test measured in 879 community-dwelling 
elderly subjects showed 4-metre walk test to be the best predictor of sarcopenia.  
The decline in physical performance measures can be considered conceptually similar to 
frailty; a state-developed due to the accumulation of multilevel system dysfunction 
predisposing an individual to decompensation. Inflammatory markers, sarcopenia, 
cerebral white matter disease and adiposity are postulated as possible pathogenic links. 
It is likely that the decline in performance measure is of multifactorial aetiology rather 
than one simple pathology, which is similar to frailty. 
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Physical performance measures and adverse outcomes 
Upper extremity function measured by the ability to pick up a full glass, touching the scapula, 
unfastening buttons, and cutting with a knife tested in 356 patients from an acute geriatric 
unit predicted adverse outcomes in hospitalised older people [46]. A prospective cohort study 
involving 2926 patients investigating the relationship between acute or critical illness and 
physical performance function showed that gait speed and chair stand speed declined 
significantly and were associated with dependence for activities of daily living [47].   
The Timed Up and Go test has been found to have a good association with history of falls but 
no association with predicting future falls in a systematic review aimed at falls prediction 
[48]. A Japanese study involving 1085 non-disabled elderly patients in the age group of 65 to 
89 years which tested gait speed, grip strength, balance test and their relationship to all-cause 
mortality reported that all three individually correlated with mortality. Combination of the 
three also proved to be significantly associated with mortality [49]. There was no association 
with cancer mortality.  
The Women’s Health and Ageing Study involving 884 participants examined separate upper 
and lower extremity function. Progressive onset of disability and the catastrophic onset of 
disability (which was considered to be present if participants were well one year before the 
onset of disability) was assessed. Gait speed predicted catastrophic disability onset. Lower 
extremity tests and summary performance scores were significantly associated with the onset 
of progressive and catastrophic disability [50]. Individuals with low physical performance 
pattern adjusted for age and gender showed a more significant association with mortality 
[51]. Gait speed and physical performance measures have also shown an association with 
hospital readmission, decline in health and function in the elderly population [52]. 
In 364 community-dwelling Italians aged more than 80 years of age, identification of 
inappropriate medication using Beers criteria was associated with worse functional 
performance [53]. Anticholinergics have also been linked with impaired physical 
performance and poor functional status [54]. Exploring the association between drug burden 
index (DBI) and function in older people indicated that for every unit increase in DBI, the 
Short Physical Performance Battery decreased by 1.3 times [55]. 
 Measurement of the effectiveness of rehabilitation in geriatric patients was studied using 
absolute functional gain (based on a change in Barthel index from admission to discharge), 
rehabilitation efficiency index (based on the functional gain over the length of stay), and 
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relative functional gain (based on percentage gain in function). Both premorbid and acute 
processes precipitating admission had a greater impact on absolute functional gain and the 
rehabilitation efficiency index compared to the relative functional gain [56]. 
Overall, physical performance measures are associated with adverse outcomes in the 
elderly population. In community-dwelling population participation in these tasks can 
be anticipated to be good but in the inpatient setting it is difficult to know how many 
will be able to engage [57] in such activity-based tasks during their initial hospital stay 
after an acute illness. Many studies done in inpatient settings have excluded people who 
could not participate in performance-based tasks on initial admission[58] [57]. 
Performance-based assessments and frailty 
Physical performance parameters such as gait speed and the Short Physical Performance 
Battery are studied as surrogate measures of frailty [59]. A systematic review aimed at 
measuring the diagnostic test accuracy of bedside simple clinical tools for identifying frailty 
showed that gait speed, and the timed up and go test showed good sensitivity with poor 
specificity [60]. The timed up and go test measure was a sensitive and specific measure of 
frailty in an Irish longitudinal study [61]. A study comparing gait speed, chair rise time, 
maximum step length and their correlation with fried phenotype and frailty index, showed 
that gait speed had the highest correlation with frailty status [62].  
Of the five components used in Fried phenotypic definition of frailty, the combination of 
slow gait speed and reduced physical activity showed the strongest association with frailty 
index as studied cross-sectionally in 484 frail elderly patients in geriatric day hospital setting 
[63]. Regardless of lean mass, treatment of muscle weakness can improve grip strength and 
physical performance measures [64]. Exercise training in the elderly population is of proven 
benefit in improving gait velocity, avoiding muscle weakness and indirectly impacting on 
frailty [65]. In a randomised control study of 51 patients assigned to 12 weeks exercise 
programme, an exercise programme improved function, strength, balance and gait speed [66]. 
Tai chi has shown to significantly improve chair rise time and cardiovascular outcomes [67]. 
Physical performance measures are essential components in frailty definition and might 
act as a useful screening tool for detailed assessment for frailty. Both show good 
association with each other but frailty is a much broader concept to explain the risk 
status of an individual than unidimensional performance measures. On the other hand 
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improvement in performance measures through exercise might have a significant 
impact on an individual’s frailty status by targeted interventions. 
Gait speed 
The Short Physical Performance Battery which includes walking speed, repeated chair stands, 
balance tests and hand grip strength displayed good predictive ability with regards to 
mortality in a community-dwelling population [68]. Walking speed has evidence as a stand-
alone parameter predicting mortality [68]. A longitudinal study involving six physical 
measures - gait speed, physical activity, hand grip strength, Body Mass Index (BMI), fatigue, 
balance  - and their  relationship to activities of daily living (ADLs) and instrumental 
activities of daily living (IADLs) showed gait speed was more predictive of ADLs and 
IADLs disability [69].  
In patients with ST-elevation myocardial infarction, gait speed was associated with 
significantly increased risk of poor cardiovascular outcomes [70]. A prospective cohort study 
of 351 older adults admitted to a transitional care programme reported that faster admission 
gait speed was associated with increased likelihood of functional independence and 
community-dwelling [71]. Pooled analysis of nine cohort studies demonstrated good 
correlation of gait speed with survival in older adults [72]. Furthermore, gait speed is an 
independent predictor of adverse outcomes after cardiac surgery [73] and is associated with 
hospitalisation in haemodialysis patients[74]. 
Male sex, medication usage and depressive symptoms were associated with gait 
characteristics in nonagenarian population [75]. Daily walking duration and its relationship to 
physical performance measures were tested in 1271 community-dwelling people aged 65-90 
years. In both men and women slow gait speed had an association with the total walking 
duration measured by the accelerometer, but in people, with higher gait speed (>0.8 
m/sec)this relationship was lost. Not all objective measures showed a relationship to walking 
duration [76]. 
In people with a fear of falling (measured by the Activities-Specific Balance Confidence 
Scale) gait speed was lower whereas the stride length and stride time variability was higher 
[77]. A Japanese study looking at the identification of appropriate performance-based test to 
determine personal care demand found slower gait speed to correlate strongly with personal 
care demand compared to chair stands, timed up and go test, grip strength [78]. Assessment 
of gait speed in the oldest old population involving people aged 85 years of age and over 
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revealed that slow gait speed and assistance with instrumental activities of daily living were 
both predictors of survival [79]. 
So, among all the physical performance measures gait speed seems to have a sound 
evidence base to predict adverse outcomes in the elderly population. 
In summary, the above narrative review of the literature has familiarised me with 
concepts of frailty, different methods to measure frail status, performance-based 
assessments and their relationship to frailty in elderly patients. Among the physical 
performance measures, gait speed has the strongest evidence base as a predictor of 
adverse outcomes. The frailty index, in comparison to the phenotypic model and other 
scales in use, provides a continuous measure of risk state. A frailty index can also be 
derived from routinely collected information. I have therefore chosen to explore the 
relationship between the frailty index as a measure of frailty status and gait speed in a 
geriatric rehabilitation setting and to explore their association with adverse outcomes. 
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1.4 Hypothesis 
The frailty index has growing evidence as a measure of frailty status and correlates with 
multiple adverse outcomes in older people. However, measuring the index in acute settings or 
in the community can be challenging due to the amount of detail required to derive an 
accurate index. Gait speed, on the other hand, is an easily measurable parameter which can be 
assessed in multiple settings in hospital care. Even though there is some available evidence 
linking physical performance measures with frailty, only a few studies have compared the 
frailty index per se with gait speed or explored their relationship to adverse outcomes. Also, 
few studies have been done in a geriatric rehabilitation setting. The predictive ability of the 
GS plus FI combination has not been explored in the literature. 
We hypothesise that gait speed correlates well with the frailty index and has similar 
predictive ability with regards to adverse outcomes in the elderly population. 
 
1.5 Aim 
To analyse the correlation of gait speed and frailty index in older inpatients on a 
rehabilitation ward and to examine their relationship to adverse events and outcomes. 
 
1.6 Objectives 
•     To assess the feasibility of deriving a frailty index (FI) from routinely collected data in 
the geriatric rehabilitation setting. 
•    To determine how many patients on a rehabilitation ward can complete an assessment of 
gait speed and to assess the adverse outcomes prevalence in each group (who could and 
couldn’t complete a gait speed assessment). 
•    To examine the relationship between FI and gait speed. 
•    To assess the predictive validity of FI, gait speed and the combination of FI/GS for 
adverse outcomes/events.  
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OVERVIEW 
In this chapter the study methods are described in detail. The setting, design, participant 
selection criteria and measures are considered followed by a detailed description of how 
variables were selected to derive the frailty index. The chapter concludes with a justification 
of sample size, account of data collection and explanation of the statistical analyses. 
2.1 Setting and Design 
This was a single centre prospective cohort study. The study was conducted in a tertiary 
teaching hospital setting in a subacute environment-geriatric rehabilitation. The study setting 
had three geriatric rehabilitation wards.  
2.2 Participants 
All patients ≥65 years admitted to the Geriatric Assessment and Rehabilitation Unit (GARU) 
from 01/03/2015 to 31/12/2015 were included. Patients were recruited from the daily 
inpatient list maintained by ward administration staff. Patients ≥ 65 years of age were 
selected, and then eligibility confirmed after excluding amputee patients. The amputee 
patients were excluded because of inability to test for normal bipedal gait.  
2.3 Measures 
Gait speed (GS) protocol 
Gait speed was recorded routinely at admission to geriatric rehabilitation by ward 
physiotherapists. Gait speed was assessed by timed 10-metre walk test done at a comfortable 
pace, with allowance for acceleration and deceleration zones and use gait aids if required. 
The time measured in seconds was converted to metre per second to derive the gait speed. 
Those who could not walk at admission were given a gait speed of 0. 
 Calculation of Frailty index (FI) 
In this study, we aimed to derive a frailty index from routinely collected data available as part 
of patient care rather than using any separate assessments. 
Characteristics of variables 
Variables and deficits that contribute to frailty index should reflect health status, should cover 
a range of systems, must not saturate with age and the prevalence should increase with age 
[80, 81].  
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1) Variables used should add information about the health status of an individual.  Participant 
demographic details such as their relationship details and living environment collected as part 
of routine care were not included as deficits. For example, living alone was not counted as a 
deficit.  
2) Variables should cover a range of systems. Cognition, communication, mood, continence, 
and functional status as part of the Functional Independence Measure (FIM) were included.  
3) To be counted as a deficit the prevalence must increase with age.  For example, chronic 
diseases tend to increase in prevalence with advancing age. 
4) Deficits counted should not be highly prevalent in the elderly population as this will not 
differentiate individual risk status. For example, in the study population, use of mobility aids 
was not counted as a deficit as the majority of patients admitted to geriatric rehabilitation use 
some form of gait aids [82]. 
The data collection sheet (see appendix 7) was designed based on these characteristics. 
Variables which were not collected in the majority of the patients were excluded in the 
derivation of the frailty index. Binary variables were given a code of 1 or 0 to indicate 
presence or absence of deficit. For ordinal variables, if a deficit is absent a score of 0 was 
given, 0.5 if present to a limited extent, 1 if fully present. 
After reviewing the information routinely collected, the following items were chosen to 
derive the FI: the Functional Independence Measure (FIM), medication count and 
comorbidities.  These items were selected as they conformed to the above characteristics 
required for FI variables both in the community [80], and in the inpatient setting [81]. 
Coding of FI variables 
The FIM comprises18 domains covering functional and cognitive components and serve as a 
measure of disability in rehabilitation services [83, 84]. Functional Independence Measure is 
comprised of 13 motor tasks and five cognitive tasks as follows. 
•    Eating 
•    Grooming 
•    Bathing 
•    Upper body dressing 
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•    Lower body dressing 
•    Toileting 
•    Bladder management 
•    Bowel management 
•    Bed to chair transfer 
•    Toilet transfer 
•    Shower transfer 
•    Locomotion (ambulatory or wheelchair level) 
•    Stairs 
•    Cognitive comprehension 
•    Expression 
•    Social interaction 
•    Problem-solving 
•    Memory 
 Each domain has a 7 point ordinal scale from the highest value of 7 representing full 
independence, to the lowest value of 1 representing full dependence[83]. The FIM is 
routinely collected in Australian Rehabilitation Units to comply with the requirements of the 
AROC (The Australasian Rehabilitation Outcome Centre). 
Using previously described methodology for coding ordinal variables in the FI [80] , FIM 
scores were categorised into deficits depending on the distribution of the data and face 
validity. Scores of 7 or 6 indicating complete independence and modified independence 
respectively were coded as 0 - the absence of a deficit. Scores from 2 to 5 indicate a 
requirement of some form of assistance. Even though the scores from 2 to 5 reflect varying 
levels of dependence, the transition from independence to requiring assistance serves as a 
major limiting factor in the discharge planning of older people. FIM scores of 2 to 5 were 
therefore allocated 0.5 for FI coding whereas the FIM score of 1 (complete dependence) was 
coded as a full deficit of 1.  
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From a set list of comorbidities (based on Charlson’s comorbidity index [85]), each 
comorbidity present was counted as a deficit. The maximum deficit count for comorbidities 
(in this case, 14) corresponded to the 98-99th percentile in the frequency distribution of the 
number of comorbidities present. Deficits for medication count were allocated based on 
frequency distributions and established cut points for categorising polypharmacy [55, 
81].Medication count of  ≥20,15-19,10-14, 5-9, 0-4 were coded as  4,3,2,1,0 deficits 
respectively. 
For FI calculation, the denominator was 36 comprising scores of 4 for medication count, 14 
for comorbidities and 18 for FIM domains.  The number of deficits present was summed and 
divided by the denominator (total deficits possible) to derive an FI. The following Table 
(Table 2.1) shows the coding for different variables. 
 Table 2.1 Frailty index coding 
Domain Cut off scoring Frailty index 
Scoring 
Denominator 
(Running total) 
Number of 
Medications 
0-4 0 0 
5-9 1 1 
10-14 2 2 
12-19 3 3 
>20 4 4 
Comorbidities Scored 1 if a comorbidity is 
present to a maximum of 15 
0 -14 18 
Functional 
Independence 
Measure  
   
Eating 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 19 
Grooming 7-Complete independence 0  
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6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 20 
Bathing 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 21 
Dressing Upper 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 22 
Dressing Lower 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 23 
Toileting 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
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2-Maximal assistance 0.5  
1-Total assistance 1 24 
Bowel Management 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 25 
Bladder 
Management 
7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 26 
Transfers-Bed –
chair 
7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 27 
Transfers-toilet 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 28 
Transfers-tub 
/shower 
7-Complete independence 0  
6-Modified independence 0  
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5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 29 
Walk 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 30 
Stairs 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 31 
Comprehension 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 32 
Expression 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
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1-Total assistance 1 33 
Social interaction 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 34 
Problem Solving 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 35 
Memory 7-Complete independence 0  
6-Modified independence 0  
5-Supervision 0.5  
4-Minimal assistance 0.5  
3-Moderate assistance 0.5  
2-Maximal assistance 0.5  
1-Total assistance 1 36 
 
Outcomes measures  
Outcome measures included adverse events/outcomes during inpatient stay such as falls, 
delirium, longer length of stay in rehabilitation, and poor discharge outcome. These were 
collected by audit of medical records. 
Falls 
All in-hospital falls are routinely documented in medical records and nursing staff follow a 
post fall pathway as required by hospital policy. Falls data were collected from medical 
records looking at the documentation by nurses, doctors, incident report forms. 
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Delirium 
Delirium data was collected by the documentation in the medical records by the medical 
team. Prevalent delirium data was collected as incident delirium data was difficult to assess 
from medical records. 
Length of stay 
Dates of admission and discharge are routinely documented in administrative records to 
enable length of stay to be calculated. Length of stay in the geriatric rehabilitation ward was 
collected separately from length of stay in the acute ward. A longer length of stay in 
rehabilitation was defined as stay > the 75th percentile of the length of stay distribution in 
rehabilitation. This was determined after analysing the frequency distribution of longer length 
of stay.  
Discharge to a higher level of care 
Discharge to a higher level of care was defined as those requiring continuing care after their 
stay in rehabilitation. Discharge to transition care or new placement in residential aged care 
were defined as discharge requiring a higher level of care. Information was collected from 
medical records. 
Poor discharge outcome 
A composite outcome measure-poor discharge outcome was defined as those who required a 
higher level of care or who died during inpatient rehabilitation. 
2.4 Sample Size  
Assuming the proportion of frailer (FI>0.25) to fitter (FI≤0.25) patients is 2:1[86], to detect a 
twofold difference in group proportions, assuming an 80% power and 5% level of 
significance, and if prevalence of poor outcome (newly admitted to institutional care or died) 
in the high frailty group is 24%[86] a sample size of 240 was required. 
2.5 Data Collection  
Following examination of routinely collected patient assessment data from all sources in the 
Geriatric Rehabilitation Unit, a data collection sheet was designed covering the participant 
characteristics required for the study (see appendix 7). Demographic details were recorded 
initially (for example, age, gender and prior living arrangements). Medication count, 
physical, cognitive and psychosocial functioning (components of the Functional 
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Independence Measure), and comorbidities were recorded from medical records. Gait speed 
was recorded as part of routine care by physiotherapists on admission and at discharge.  
Once all data collection was completed, participants were assigned a unique identification 
code and then entered into the specially designed excel spreadsheet, which was exported to 
SPSS (statistical software) for further analysis. According to ethics requirements, all data are 
stored securely in the Centre for Health Services Research, Princess Alexandra Hospital and 
will be destroyed after seven years or once all the publications are completed. 
2.6 Ethics 
Approval for this low-risk study was given by the Metro South Health Human Research 
Ethics Committee (HREC/15/QPAH/140 on 7 April 2015 refers). The Site-Specific 
Agreement (SSA/15/QPAH/142) was approved on 28 April 2015, and the Public Health Act 
approval for access to confidential health information with a waiver of patient consent was 
obtained on 27 April 2015.  
2.7 Analysis 
SPSS version 23.0 (IBM Corp., Armonk, NY) was used for data analysis. Frequency 
distributions described participant characteristics. Logistic regression analysis was used for 
categorical outcomes adjusting for age and gender. Correlation statistics were used for 
assessing the correlation between the frailty index and gait speed. ROC curve/AUC analysis 
was conducted for frailty index and gait speed against each outcome. Based on the ROC 
analysis, cut points  for FI and GS were chosen based on the level at which maximum 
sensitivity and specificity were present.  
Based on the cut points, the participants were divided into four groups in differing 
combinations of FI and gait speed and outcomes were analysed against each group. The 
participants were grouped into less frail (≤ 0.40) and more frail (>0.40) using an FI cut point 
of 0.40 to designate higher frailty.  Gait speed was grouped as those who could (GS>0) and 
could not walk (GS=0) at rehabilitation admission. 
The participants were categorised as following 
Group A – GS = 0 and FI >0.40 (those who could not walk at rehabilitation admission and 
more frail) 
Group B – GS = 0 and FI ≤0.40 (those who could not walk and less frail) 
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Group C – GS > 0 and FI >0.40 (those who could walk at rehabilitation admission and more 
frail) 
Group D – GS > 0 and FI ≤ 0.40 (those who could walk at rehabilitation admission and less 
frail). 
The participants were also divided into two groups based on gait speed, those who could 
complete an assessment of gait speed at geriatric rehabilitation admission (GS>0) and those 
who could not (GS=0). Adverse outcomes between the groups were compared. For ease of 
interpretation of odds ratio FI was multiplied by a factor of 10. 
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Overview 
This chapter presents the results of the thesis. First, the characteristics of participants are 
described followed by detailed reports of the characteristics and predictive ability of both the 
frailty index and gait speed. The correlation between the two measures is presented as a 
figure. The question of whether the combination of frailty index and gait speed adds value in 
predicting risk of adverse outcomes is considered before comparisons of the ROC /AUC 
analyses of each measure. The chapter concludes by reporting the prevalence of adverse 
outcomes in the groups who could and couldn’t mobilise at rehabilitation admission. 
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3.1 Participant characteristics 
Of 258 participants recruited, 139 (54 %) were females. The mean (SD) frailty index was 
0.42 (0.13) and mean (SD) gait speed was 0.26 (0.33) m/sec. Characteristics of the study 
population are shown in Table 3.1 
Table 3.1 Characteristics of the study population 
Participant Characteristics N=258 
Age in years Mean (SD) 79 (8) 
Female n (%) 139 (54%) 
Number of medications Median (IQR) 9 (6-11) 
Number of comorbidities Median (IQR) 6 (4-7) 
Rehabilitation length of stay in days Mean (SD)  41.6 (35.9) 
Admission Source n (%) 
Community 
RACF/Other hospital 
  
234 (91%) 
 24 (9%) 
Frailty index Mean (SD) 0.42 (0.13) 
Gait speed m/sec Mean (SD) 0.26 (0.33) 
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3.2 Frailty index 
Feasibility 
The frailty index derivation from routinely collected data as part of geriatric rehabilitation 
was feasible. There were no missing data. All participants were able to have a frailty index 
derived.  
Characteristics 
FI was normally distributed reaching a submaximal limit of 0.69, conforming with 
parameters found in other published studies [81].  
 
Figure 3.1-Frailty index distribution 
Prediction of adverse outcomes 
FI’s predictive ability against adverse outcomes was tested using univariate and logistic 
regression analysis adjusting for age and gender. Univariate analyses showed significant p 
52 
 
values for delirium (0.012), longer length of stay (<0.001), poor discharge outcome (0.001) 
(see Table 3.2). 
 The odds ratios (CI) for delirium, falls, longer length of stay, discharge to higher care/death 
were 1.38 (1.06-1.78), 1.31 (0.99-1.72), 2.13 (1.60-2.83), 1.38 (1.11-1.70) respectively (see 
Table 3.3) in regression analyses.  
3.3 Gait speed 
Feasibility 
Gait speed was able to be measured in 125 (48.4 %) participants at admission to geriatric 
rehabilitation, three had missing data, and 130 (50.4%) participants were unable to complete 
the test due to their functional status impacting their ability to undertake the timed ten-metre 
walk test. Those who were unable to participate were allocated a gait speed of 0. Mean (S.D) 
gait speed was 0.26 m/s (0.33). 
Characteristics 
The mean gait speed here was 0.26 m/s for all the participants and 0.54 m/sec for the 
participants who could undertake an assessment. The mean gait speed of 0.54 m/sec at a 
comfortable pace is similar to published studies in subacute environment [57]. 
Prediction of adverse outcomes 
On univariate analyses gait speed showed significant p values in relation to predicting 
delirium (0.032), longer length of stay (<0.001)and poor discharge outcome (<0.001) (see 
Table 3.2). 
On logistic regression analysis, adjusting for age and gender, the odds ratios (CI) for 
delirium, longer length of stay, and poor discharge outcome were 0.87 (0.77-0.98), 0.75 
(0.66-0.86), 0.83 (0.75-0.91) respectively (see Table 3.3). For each 0.1m/s increase in gait 
speed, there was 13% less chance of delirium, 25% less chance of longer length of stay and 
17% less chance of discharging to higher care or mortality. The values for falls were not 
significant (see Table 3.3). 
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Table 3.2 Univariate analysis of relationship of FI and GS with outcomes 
Outcome  
 
N=258 
N (%) 
Frailty 
index 
Mean(SD) 
P Gait speed 
Mean(SD) 
p 
LOS > 55 
days (75th 
percentile) 
65(25) 0.49 (0.10) <0.001 0.12 (0.29) <0.001 
Discharge 
outcome 
  0.001  <0.001 
Usual 
residence 
139(54) 0.40(0.13)  0.34(0.35)  
Higher level 
of care 
109(42) 0.44(0.11)  0.18(0.29)  
Deceased  10(4) 0.51(0.14)  0.04(0.13)  
Delirium 53(20) 0.46(0.13) 0.012 0.18(0.28) 0.032 
Fall 43(17) 0.46(0.10) 0.036 0.22(0.32) ns 
 
 
Table 3.3 Logistic regression analysis of association of FI and GS with outcomes  
Outcome  
 
 Frailty index   
ORCI) 
Gait speed  
OR(CI) 
Delirium 1.38(1.06-1.78) 0.87(0.77-0.98) 
Falls 1.31(0.99-1.72) 0.94(0.84-1.06) 
Longer Length of Stay 2.13(1.60-2.83) 0.75(0.66-0.86) 
Discharge to higher care/death 1.38(1.11-1.70) 0.83(0.75-0.91) 
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3.4 Correlation of gait speed and frailty index 
Correlation analysis showed that gait speed and frailty index were negatively correlated with 
Pearson’s coefficient of -0.396 and a significant p-value (<0.001). As the frailty index 
increased the gait speed decreased, reflecting the worsening overall health status of the 
individual. 
 
 
 
Figure 3.2-Frailty index and Gait speed correlation 
 
3.5 Combining FI and GS and predictive ability for adverse outcomes 
We also analysed how the combination of the two parameters (FI and GS) predict adverse 
outcomes given the moderate correlation shown between the two measures. 
The participants were divided into four groups  
 Group A- GS=0 and FI>0.40 (those who could not walk at rehabilitation admission and more 
frail defined by a cut point of FI at 0.40)  
 Group B-GS=0 and FI ≤0.40 (those who could not walk and less frail) 
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Group-C GS=1 plus FI>0.40(those who could walk at rehabilitation admission and more 
frail) 
 Group-D GS=1 and FI≤0.40 (those who could walk at rehabilitation admission and less 
frail). 
Compared to Group A (the reference group), the OR (95% CI) for risk of delirium in Groups 
B, C, D was 0.61 (0.25-1.52), 0.54 (0.23-1.23), 0.30 (0.12-0.71) respectively. With longer 
length of stay, groups B, C, D had OR (95% CI) of 0.16 (0.06-0.41), 0.17 (0.07-0.41), 0.06 
(0.02-0.16) respectively compared to group A. For the outcome of needing higher care or 
mortality, Group B was not significantly different from Group A (OR-1.07 (0.49-2.34). 
Groups C and D had OR of 0.35 (0.17-0.73), 0.28 (0.14-0.55) respectively.  
In Summary the ability to mobilise at rehabilitation admission and being less frail is 
protective with a less likelihood of developing adverse outcomes (see Table 3.4, Figures 3.3, 
3.4, 3.5). 
 
Table 3.4 Adverse outcomes by combined parameters 
GS/FI GROUPS DELIRUM 
OR(CI) 
LONGER 
LENGTH OF 
STAY GARU 
OR(CI) 
DISCHARGE TO 
HIGHER CARE 
OR DEATH 
OR(CI) 
Group A 
GS=0 PLUS FI>0.40 
1 1 1 
Group B 
GS=0 PLUS FI<0.40 
0.61 (0.25-1.52) 0.16 (0.06-0.41) 1.07 (O.49-2.34) 
Group C 
GS=1PLUS FI>0.40 
0.54 (0.23-1.23) 0.17 (0.07-0.41) 0.35 (0.17-0.73) 
Group D 
GS=1PLUS FI<0.40 
0.30 (0.12-0.71) 0.06 (0.02-0.16) 0.28 (0.14-0.55) 
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 Figure 3.3-Prevalence of delirium 
 
 
  
Figure 3.4-Prevalence of longer length of stay 
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Figure 3.5 Prevalence of discharge to higher care/mortality 
 
3.6 FI, GS- Is one better than other? 
AUC analyses indicated that neither measure was fully able to discriminate who developed 
adverse events or outcomes from those who did not. 
FI’s AUC for adverse outcomes ranged from 0.60-0.70 and for GS it ranged from 0.54-0.69. 
A cut point of 0.40 for FI and 0.20 for GS was chosen as the sensitivities and specificities for 
adverse outcomes were maximal at that point.  
At a cut point of 0.40, FI was more specific than GS for adverse outcomes whereas gait speed 
at a cut point 0.20 was more sensitive in adverse outcomes prediction (see Tables 3.5 and 3.6) 
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Table 3.5 Frailty index -AUC 
 
 
 
Table 3.6 Gait speed-AUC 
 
 
3.7 Comparison of gait speed groups 
The participants were divided into two groups based on their ability to participate in gait 
speed assessment. Those who could not undertake an assessment were given a gait speed of 
zero (could not walk-GS=0 group). The rest who had an admission gait speed were 
categorised to GS>0 group. 
A total of 130(50.4%) participants had a gait speed of zero and 125 were in GS>0 group. The 
male and female proportions were equal across both groups. Median comorbidities count, 
Outcomes  AUC Sensitivity at FI 
>0.40 
Specificity  at 
FI >0.40 
Delirium 0.605 36% 74% 
GARU LOS >55 days 0.705 51% 80% 
Discharge to higher care/death 0.607 35% 78% 
Falls 0.602 37% 74% 
Outcomes  AUC Sensitivity at 
Gait speed ≤0.2 
Specificity  at 
Gait speed ≤0.2 
Delirium 0.608 72% 51% 
GARU LOS >55 days 0.688 85% 56% 
Discharge to higher care/death 0.640 69% 58% 
Falls 0.543 63% 48% 
59 
 
mediation count were similar between the two groups. Mean (SD) gait speed in GS>0 group 
was 0.54m/sec (0.27). 
A higher proportion in the GS=0 group had delirium, longer length of stay, discharge to a 
higher level of care and death compared to GS>0 group (see Table 3.8). Of those who could 
mobilise at rehabilitation admission 68% of people returned to their usual residence (GS= 1 
group) whereas only 40 % returned to their usual residence in GS=0 group. 
Adjusting for age and gender in regression analysis the odds ratios (CI) for delirium, longer 
length of stay, discharge to a higher level of care were 2.23 (1.18-4.21), 6.07 (3.06-12.06), 
3.29 (1.95-5.55) respectively (Table 3.7)  
 
Table 3.7 Characteristics Gait speed groups  
 
PARTICIPANT 
CHARECTERISTICS 
GAIT SPEED 
ADMISSION=0 
N=130 
GAIT SPEED 
ADMISSION>0 
N=125 
Age in years Mean(SD) 79(8.9) 79(7.5) 
Gender –Female (%) 
                 Male (%) 
45% 
55% 
48% 
52% 
Number of medications –
Median(IQR) 
8(6-11) 9(7-11) 
Number of comorbidities –Median 
(IQR) 
6(4-7) 5(4-8) 
Admitted from 
Community 
Other 
 
89% 
11% 
 
92% 
8% 
Gait speed –Mean(SD)-m/sec 0(0) 0.54(0.27) 
Frailty index –Mean(SD) 0.47(0.12) 0.37(0.11) 
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Table 3.8 Adverse Outcomes Gait speed groups 
Outcome 
N (%) 
GAIT SPEED 
ADMISSION=0 
N=130 
GAIT SPEED 
ADMISSION>0 
N=125 
p value OR(CI) 
Delirium 
 
35(26.9%) 18(14.4%) 0.014 2.23(1.18-4.21) 
GARU length of 
stay>55days(75th 
percentile) 
52(40.0%) 13(10.4%) <0.001 6.07(3.06-12.06) 
Discharge Outcome 
 
Usual residence 
  
Higher level of care 
  
Death 
 
 
52(40.0%) 
 
69(53.1%) 
 
9(6.1%) 
 
 
85(68.0%) 
 
39(31.2%) 
 
1(0.8%) 
 
 
 
 
≤0.001 
 
 
 
 
3.29(1.95-5.55) 
Fall 
 
26(20.0%) 17(13.6%) ns 1.64(0.84-3.21) 
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Chapter 4 
                        Discussion 
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OVERVIEW 
In this fourth and final chapter, the findings of my program of work will be summarised. 
Results are contextualised with other studies in this field before consideration of their clinical 
implications. The strengths and limitations are carefully explored and recommendations made 
for future avenues of investigation. A concluding summary draws the thesis to a close. 
  
4.1 Summary of Findings 
This study shows that it is feasible to derive an FI using routinely collected data in geriatric 
rehabilitation. The derived FI was normally distributed and conformed to expected 
characteristics of an FI reaching a submaximal limit. Gait speed on the other hand even 
though feasible, was limited by the participants' ability to undertake the test based on their 
functional status at rehabilitation admission.  
 
Both FI and GS have predictive validity for adverse events /outcomes on univariate and 
regression analysis adjusting for age and gender. Neither FI nor GS is discriminatory based 
on the AUC analysis for adverse outcomes, but the combination of the two is more 
informative. Those who were frailer and could not mobilise at rehabilitation admission were 
at more risk of adverse outcomes. The participants who could not mobilise on entry to 
rehabilitation had a higher prevalence of adverse outcomes than those who could undertake 
an assessment of gait speed. 
 
4.2 Contextualisation with existing studies 
The participant characteristics (age, the proportion of male /female, prior community living 
status, principal admission diagnoses) are comparable with other studies in geriatric 
rehabilitation settings [86, 87]. As shown in previous studies in acute care [81] and 
rehabilitation settings [86], the characteristics of the FI are similar, and higher levels of frailty 
are significantly associated with the adverse event of poor discharge outcome. The outcomes 
for our cohort, for example, the proportion of people returning to the usual residence from 
rehabilitation and those requiring higher care, are also similar to existing studies [87]. 
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The mean FI of 0.42 indicates a moderate to severely frail population [34]. The FI derived 
here is normally distributed reaching a submaximal limit of 0.69 fitting with the expected 
characteristics of an FI [28, 81]. The cut-off point of 0.40 for optimal sensitivity and 
specificity for adverse outcomes is similar to studies in acute settings [31]. The 0.40 value 
also lies between moderately frail (corresponding FI of 0.36) and severely frail 
(corresponding FI of 0.43) categories of the Clinical Frailty Scale [34]. The continuous nature 
of the FI is very attractive for risk prediction, as it allows more granularity in decision-
making for various interventions, for example, preoperatively. On the other hand, an FI cut 
point of 0.40 for risk prediction might be useful as a trigger for Comprehensive Geriatric 
Assessment [22]. This needs further testing and exploration in different settings and 
scenarios.  
 
The proportion of people with a gait speed of zero was more than half the participants in this 
cohort. There is a paucity of literature into the methodology of allocating a gait speed of zero, 
as most studies exclude those who are unable to participate in walking speed assessment [57]. 
The mean gait speed of the group who were able to mobilise was 0.54 m/sec (SD 0.27), 
similar to other studies in subacute settings [57]. The wide distribution of FI (0.2-0.6) in the 
cohort who were unable to walk has good face validity: an inability to undertake a 
performance-based assessment could indicate a higher risk state, or it may be a temporary 
manifestation of an acute, reversible insult (e.g. fractured lower limb).  The proportion of 
people who could not mobilise at admission, appears larger but is similar to the ability to 
undertake other performance-based measures like the functional reach, timed up and go test 
[58]. Possible explanations for this could be their frailty status or impact of the acute illness 
or change in health status due to hospitalisation. Previous studies [88] have shown a 
relationship between gait speed and adverse outcomes in the community-dwelling population. 
Here, in an inpatient geriatric rehabilitation setting as well those who could not participate in 
a timed walk test were at more risk of adverse outcomes like falls, delirium, and longer length 
of stay. 
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4.3 Clinical Implications 
The ability to derive a frailty index from routinely collected data in rehabilitation settings 
offers an enormous advantage. The variables used here to derive an FI are collected in most 
rehabilitation settings. One of the main criticisms of frailty index method is the amount of 
time needed in deriving the index [89]. Here the usage of routinely collected data makes it 
easier to derive an FI without any need for additional data collection. The FIM is routinely 
undertaken for the funding purposes in rehabilitation settings [90]. Comorbidities are 
documented in medical admission notes as part of the assessment of the treating team. The 
pharmacist usually undertakes medication review in most hospital settings, and this detail is 
available in medical notes and daily medication chart. This method has the potential to offer a 
consistent and universal method of frailty measurement in all Australian rehabilitation 
settings.  
 
The FI approach conceptualises frailty as a continuous measure with the potential to change 
with an individual’s hospital journey. Here the FI was based on current status rather than 
baseline vulnerability. While previous studies have shown that both measures are associated 
with adverse outcomes [91], further work is needed to establish if the difference in baseline 
and current status has better predictive validity than either measure alone. Using a continuous 
variable like FI also offers more granularity in decision making. One potential pitfall that 
geriatricians intuitively fear is that a higher score may be used to justify therapeutic nihilism 
leading to poorer outcomes. The derived FI is just one of the factors that may support 
decision making. In hospitalised patients, it is important to consider multiple factors: the 
acuteness of the medical illness, its severity, premorbid function, patients’ perspective of 
their health status and their valued goals. Further research exploring the relationship between 
health assets and adverse outcomes is needed [92].  
  
Medical records are increasingly becoming digital. Currently, many hospitals in Queensland 
are using digital records. With the expected technological progress it is likely that the 
digitalisation of medical records will become increasingly common. This offers great scope 
for automatic frailty measurement. This type of automatic measurement is an area of future 
research with studies starting to emerge in primary care settings where an automatic measure 
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of frailty is available for use [32]. Future research exploring the clinical utility of such 
derived FI is needed. 
 
Gait speed and other performance measures offer the advantage of ease of measurement. 
However, in a hospitalised population as shown in our study only less than half the 
participants could undertake the test. Frailty index, on the other hand, was able to be derived 
in all the participants providing the advantage to have a measure of risk prediction for all. 
Those who cannot mobilise will be able to have an FI derived. Using the combination 
provides more information than each of the measures alone. The group who were frailer 
(FI>0.40) and immobile were at more risk of adverse outcomes. It would be useful to use 
both when feasible. The FI and GS were each predictive of poor outcomes suggesting they 
can both add value in understanding the risk status of an individual and in making informed 
decisions. However, AUC analyses indicate that neither fully explains risk status. Evidence is 
emerging that protective factors (health assets such as the support of a caregiver, higher 
health literacy and economic resources) can mitigate adverse outcomes for frail older 
inpatients [92].  
 
Frailty status and gait speed at rehabilitation admission are both reflective of an individual’s 
health status after an acute insult, but they may capture different domains. Many components 
of the FI, for example, the number of comorbidities, vision and hearing problems will not 
change during the rehabilitation episode and are reflecting deficits that have been 
accumulated as a result of ageing. GS may be zero due to the acute insult or because of age-
related sarcopenia, executive dysfunction, neuromuscular degeneration, bone/joint disease, 
metabolic changes or altered perceptual system [93]. The presence of multisystem age-related 
deficits predisposes an individual to be more prone to immobility in the context of an acute 
insult [94]. The combination of higher FI and gait speed of zero in an inpatient setting may be 
capturing people who have a very high number of age-associated deficits or who have had a 
significant acute insult on a background of a vulnerable state. As bipedal ambulation is a 
complex task requiring integration of various body systems, the preservation of walking 
ability even in the frailer group indicates their ability to compensate for other accumulated 
deficits. In this study, the preserved ability to walk despite being frailer (Group C) also 
translates to better outcomes compared to the more frailer and immobile group (Group A). 
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Identification of the at-risk population using GS and FI offers potential avenues to improve 
clinical management. Goals can be tailored, and rehabilitation therapies can be altered 
depending on the risk profiles. This has the potential to facilitate well-informed 
communication with families. Further studies to assess the benefit of targeted interventions in 
improving patient outcomes are needed. This future work may confirm that the identification 
of populations at higher risk can lead to interventions that can improve outcomes. In addition, 
since Comprehensive Geriatric Assessment is of proven benefit in the management of frail 
older inpatients [95] , the FI may serve as a screening tool for geriatric consultation and 
individualising medication prescription [96]. 
 
4.4 Strengths and limitations 
Our findings have significant strengths.  This is the first study to explore the derivation of an 
FI using routinely collected data in Australian rehabilitation settings. Also, the feasibility of 
performance measures like gait speed in a hospitalised population has not been explored in 
existing studies. Besides, comparing the two measures, GS and FI in the same setting offers 
advantage. Our findings add clarity that performance-based assessments despite the ease of 
use is limited by the ability to participate. The combination approach for predicting risk needs 
further exploration. 
 
There are limitations to our results. This is a single centre study, and the results may not be 
generalizable to other settings. The cohort of participants recruited might have been impacted 
by local demographics of hospital location, local hospital policy and guidelines regarding 
rehabilitation. The predictive ability of the derived FI is likely to be impacted by the 
disability component due to the setting of the study (geriatric rehabilitation where the primary 
goal is the restoration of function). The data collection was based on chart analysis which 
might have introduced misidentification and misclassification of details impacting results. 
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4.5 Future direction 
Future studies to replicate the study findings in other geriatric rehabilitation settings would be 
useful. The method used here for FI derivation (using the FIM, comorbidities, medication 
count) needs replication in other rehabilitation settings to confirm generalisability. With the 
anticipated digitalisation of medical records, the feasibility of automatic frailty measurement 
should be an area of focus. Studies investigating whether an awareness of frailty status 
changes the management decisions translating to improved outcomes also needs further 
clarification.  
 
Developing targeted interventions after identification of at-risk people and assessing if those 
interventions improve outcomes are essential next steps. There is a surge of evidence 
showing association of frailty status with adverse outcomes with limited studies focussing on 
interventions [97]. The impact of targeted rehabilitation on frailty status needs exploration. In 
particular, longer periods of therapy have the potential to be of benefit for frail older 
inpatients due to their increased recovery times [4]. Frailty measurement on discharge could 
help to identify the association between frailty status and readmission, future adverse health 
outcomes and health care utilisation.  
 
Alternative tests assessing balance and mobility in elderly patients like the hierarchal 
assessment of balance and mobility (HABAM) may be informative since they can be 
administered to immobile patients [98, 99]. The association between change in gait speed and 
adverse outcomes in an inpatient setting may also be informative.  
 
Future studies are needed as priority to address how identifying at-risk people translates to 
change in clinical management decisions and how that change impacts outcomes of this 
vulnerable cohort . 
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Conclusion 
The results from this thesis shows that risk stratification of older patients at entry to 
rehabilitation is feasible by frailty status measurement using frailty index and gait speed. It is 
possible to create an FI using routinely collected data in a rehabilitation setting.  Although the 
feasibility of gait speed was limited by the participants’ ability to undertake an assessment, 
gait speed of zero was still informative. Both measures were predictive of adverse outcomes. 
The combination of being frailer and unable to mobilise at rehabilitation admission seems to 
denote a higher risk state. Future research should focus on whether the awareness of this risk 
state impacts clinical decision-making and changes patient outcomes. Further work on 
developing specific interventions for this population needs exploration. 
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Appendix 3-Abstract 1 
Feasibility and validity of frailty measurement in geriatric rehabilitation 
Aims: 
Frailty status assessment using Frailty index (FI) model (based on deficit accumulation) has 
been criticised as time consuming for use in hospital settings. Here we aimed to assess the 
feasibility of deriving an FI based on routinely collected data and its predictive ability against 
adverse outcomes. 
Methods: 
258 participants patients aged 65 and older were included in a single centre prospective 
cohort study conducted in inpatient geriatric rehabilitation wards. Variables that contribute to 
a frailty index should reflect health status, cover a range of systems, not saturate with age and 
generally increase in prevalence with age. Based on these criteria, components of the 
Functional Independent Measure, medication count and comorbidities were coded as deficits. 
These were recorded by the multidisciplinary team as part of usual care. 
Results: 
An FI could be derived in all 258 participants. It conformed to expected characteristics, with 
a normal distribution around a mean (SD) of 0.42(0.13) and reaching a submaximal limit of 
0.69. Adjusting for age and gender, each 0.1 increase in FI increased the likelihood of longer 
length of stay, worse discharge outcome, delirium by 2.13(95% CI 1.60-2.83), 1.42(CI 1.15-
1.75), 1.37(CI 1.06-1.78) times respectively. 
Conclusion: 
This study shows that deriving an FI from routinely collected data is feasible in geriatric 
rehabilitation settings and has predictive ability for adverse outcomes in this population. With 
the increasing use of electronic health records there is potential to compute an FI in all 
rehabilitation setting as the variables used are routinely collected in most centres. 
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Appendix 4-Abstract 2 
Prognostic significance of gait speed of zero 
Aims: 
In community-dwelling older people, slower gait speed (GS) predicts multiple adverse 
outcomes, yet those who are unable to walk are excluded from most studies.  Here we 
assessed how many older inpatients could complete a timed walk test at admission to a 
rehabilitation ward and investigated the prognostic significance of a GS of zero, assigned to 
those unable to complete timed walk. 
Methods: 
In a prospective cohort study, patients aged 65 years and older were recruited from 3 
rehabilitation wards at a tertiary referral centre. Gait speed was assessed at admission using 
the timed ten metre walk test at comfortable pace allowing use of gait aids, if required. 
Participants were grouped according to those able to complete the test (GS>0) and those 
unable (GS=0).  
Results: 
Of 258 participants, 255 had gait speed assessed (3 were missing data). Of those, 130 (51 %) 
were unable to walk on admission. Mean (SD) gait speed in the mobile group was 0.54m/sec 
(0.27). After adjusting for age and gender, logistic regression analyses showed those with   
GS =0 were more likely to have adverse outcomes such as delirium (OR 2.23 CI-1.18-4.21), 
longer length of stay (OR 6.07 CI 3.06-12.06), and discharge to higher care or death (OR 
3.29 CI 1.95-5.55). 
Conclusion: 
Over half the study participants were unable to complete gait speed assessment at 
rehabilitation admission and were at significantly higher risk of adverse outcomes. Gait speed 
is a simple test that should be used more routinely in risk stratification for older inpatients.  
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Appendix 5-Abstract 3 
Gait speed and frailty status in relation to adverse outcomes in older inpatients: A 
prospective cohort study 
Aims: Both gait speed and measures of frailty are associated with adverse outcomes in 
community-dwelling older people. However using these measures to assess vulnerability in 
inpatient geriatric rehabilitation has yet to be explored. Here we aim to assess the feasibility of 
deriving a frailty index (FI) from routinely collected data in geriatric rehabilitation, to examine 
the relationship between FI and gait speed and their ability to predict adverse outcomes. 
Methods: All patients aged 65 and older were included in a single centre prospective cohort 
study conducted in inpatient geriatric rehabilitation wards. Data routinely recorded as part of 
comprehensive geriatric assessment, including gait speed, were collected contemporaneously. 
The FI was calculated as accumulation of deficits across multiple domains of the Functional 
Independence Measure, number of comorbidities and medications, using a well-defined 
methodology. 
Results: 258 participants were recruited. Mean age was 79 years and 54% were females. Mean 
(Standard deviation) FI on admission was 0.42(0.13) and gait speed was 0.26 (0.33) m/sec. 
Those unable to complete a timed-walk on admission (50%) were allocated a gait speed of 0. 
FI correlated significantly with gait speed (coefficient -0.396). Both parameters were 
significantly associated with longer length of stay (>75th percentile), worse discharge outcome 
(to supported care or died), and delirium, but not with inpatient falls. 
Conclusion: 
This study shows that deriving a FI from routine patient assessment data is feasible for all 
patients, while only half the study participants could complete the timed-walk. Both measures 
showed predictive validity for adverse outcomes. 
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Appendix 7-Data collection form 
Date of Birth (dd/mm/yyyy) / / 
Date admitted to acute care  / / 
Date admitted to Garu  / / 
Date of discharge/death  / / 
Gender (circle) 1. Male 2. Female
No. regular medications at GARU admission 
Admitted to acute care from (circle) 
1. Community 2. IHT 3. Residential Care (low/high)
Discharge destination (circle)
1. Usual residence 2. IHT 3. Entry into residential care (low/high) 4. TCP resi/community 5. Death
Complications during GARU admission (circle- if no complications circle zero for each option) 
Falls 0 No 1 Yes Delirium 0 No 1 Yes Pneumonia 0 No 1 Yes VTE 0 No 1 Yes AKI 0 No 1 Yes 
Other 0 No 1 Yes (specify) 
10m walk time admission: • (secs) 99 Unable to walk (Ill/injured) - walk time blank 
88 Did not walk (Specify Reason) 
10m walk time discharge: • (secs) 99 Unable to walk (Ill/injured) - walk time blank 
88 Did not walk (Specify Reason) 
Primary diagnosis for rehab admission 
FIM (Score 1-7) Admission Discharge FIM (Score 1-7) Admission Discharge 
Eating Grooming 
Bathing 
Dressing -upper Dressing -lower 
Toileting 
Bowel  Management Bladder Management 
Transfers(bed/chair) Transfers-toilet 
Transfers –tub/shower 
Walk Stairs 
Comprehension Expression 
Social interaction Problem Solving 
Memory 
90 
*NB: 0 or 1 must be circled for every disease condition. If neither choice is circled is suggests the
data is missing because it hasn’t been investigated or absence/ presence could not be ascertained.
Disease Group Disease Condition Present Absent Disease Condition Present Absent 
Cardiovascular 
Disease 
MI 1 0 IHD 1 0 
CCF 1 0 AF 1 0 
PVD 1 0 HTN 1 0 
Hyperlipidaemia 1 0 F/Hx of CV disease 1 0 
Renal Failure CRF 1 0 ESRF on dialysis 1 0 
Smoking Status 
Current smoker 1 0 Ex-smoker 1 0 
Never smoked 1 0 
Neurological 
Disorder 
Dementia 1 0 Epilepsy 1 0 
Parkinson’s disease 1 0 Multiple Sclerosis 1 0 
Spinal cord injury 1 0 Traumatic brain injury 1 0 
Visually impaired 1 0 Hearing impaired 1 0 
CVA CVA/TIA 1 0 CVA with hemi 1 0 
Neuropsychiatric 
Depression 1 0 Bipolar 1 0 
Schizophrenia 1 0 Drug and alcohol abuse 1 0 
Respiratory COAD/Asthma 1 0 Other chronic lung disease 1 0 
Gastrointestinal GORD 1 0 Peptic ulcer disease 1 0 
Liver Mild  CLD 1 0 Severe CLD 1 0 
Endocrine Hypothyroid 1 0 Osteoporosis 1 0 
Diabetes Mellitus Diabetes 1 0 DM - end stage organ damage 1 0 
Malignant 
Condition 
Cancer 1 0 Cancer with metastasis 1 0 
Leukaemia 1 0 Lymphoma 1 0 
Miscellaneous 
Condition 
Connective tissue disorder 1 0 AIDS 1 0 
Osteoarthritis 1 0 Morbid obesity 1 0 
Other (specify) 
Other (specify) 
Other (specify) 
Other (specify) 
Date data entered 
Initials 
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Appendix 8-FI and Gait speed data entry/coding guide 
Gender  Enter 1 or 2
 Blanks will mean data is missing
No. regular medications at GARU 
admission 
 Numerical
 Blanks will mean data is missing
Admitted to acute care from  Numerical between 1 and 3
 Blanks will mean data is missing
Discharge destination  Numerical between 1 and 5
 Blanks will mean data is missing
Complications during GARU 
admission 
 Enter 0 or 1 for all identified complication fields
 Blanks will mean data is missing
 If “other”=1, text description must be entered in “specify” field
 Blanks when “other”=1 will mean data is missing
10m walk time admission/discharge  Numerical in seconds to as many decimal places as recorded
 Blanks will mean data is missing unless “walk time”=88
 If “walk time”=88 text description must be entered in “specify” field
 Blanks in “specify” field when “walk time”=88 will mean data is missing
Primary diagnosis for rehab admission Text 
FIM (all) Numeric between 1 and 7 
Comorbidities  Enter 0 or 1 for all listed comorbidities
 Blanks will mean data is missing
 Unlisted comorbidities are entered as text descriptions in “other” fields
 Blanks in “Other ” fields will mean no additional unlisted comorbidities
